Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Answer questions and earn CME/CNE

[1]  S. Asa,et al.  Controversies in Thyroid Pathology: Thyroid Capsule Invasion and Extrathyroidal Extension , 2010, Annals of Surgical Oncology.

[2]  Su-jin Kim,et al.  Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer , 2015, PloS one.

[3]  J. Shah,et al.  The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer. , 2011, Surgery.

[4]  K. Pathak,et al.  The age factor in survival of a population cohort of well-differentiated thyroid cancer , 2013, Endocrine connections.

[5]  A. Miyauchi,et al.  Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. , 2009, Endocrine journal.

[6]  K. Pathak,et al.  Identifying the most appropriate age threshold for TNM stage grouping of well-differentiated thyroid cancer. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  Kwang Hee Kim,et al.  Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma. , 2013, International journal of surgery.

[8]  R. Tuttle,et al.  Update on differentiated thyroid cancer staging. , 2014, Endocrinology and metabolism clinics of North America.

[9]  E. Baudin,et al.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. , 2005, The Journal of clinical endocrinology and metabolism.

[10]  A. Miyauchi,et al.  Establishment of an Intraoperative Staging System (iStage) by Improving UICC TNM Classification System for Papillary Thyroid Carcinoma , 2010, World Journal of Surgery.

[11]  E. Bergstralh,et al.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. , 1993, Surgery.

[12]  J. Shah,et al.  Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure. , 2015, Thyroid : official journal of the American Thyroid Association.

[13]  J. Shah,et al.  Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It? , 2015, Thyroid : official journal of the American Thyroid Association.

[14]  T. Klonisch,et al.  Prognostic nomograms to predict oncological outcome of thyroid cancers. , 2013, The Journal of clinical endocrinology and metabolism.

[15]  J. Jonklaas,et al.  The impact of age and gender on papillary thyroid cancer survival. , 2012, The Journal of clinical endocrinology and metabolism.

[16]  J. Shah,et al.  Thyroid – Differentiated and Anaplastic Carcinoma , 2017 .

[17]  S. Roman,et al.  Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Roman,et al.  Extrathyroidal Extension Is Associated with Compromised Survival in Patients with Thyroid Cancer. , 2017, Thyroid : official journal of the American Thyroid Association.

[19]  D. Chang,et al.  A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry. , 2012, Surgery.

[20]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[21]  A. Stojadinovic,et al.  Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome. , 2014, Thyroid : official journal of the American Thyroid Association.

[22]  Nancy D Perrier,et al.  Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? , 2017, Thyroid : official journal of the American Thyroid Association.

[23]  Z. Hall.  Cancer , 1906, The Hospital.

[24]  R. Ghossein.  Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin. , 2009, Archives of pathology & laboratory medicine.

[25]  S. Roman,et al.  Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Shah,et al.  An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer. , 2016, Thyroid : official journal of the American Thyroid Association.

[27]  Tae Yong Kim,et al.  Clinicopathological Significance of Minimal Extrathyroid Extension in Solitary Papillary Thyroid Carcinomas , 2015, Annals of Surgical Oncology.

[28]  T. Fahey,et al.  Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma. , 2008, Surgery.

[29]  H. Dralle,et al.  Determinative Factors of Biochemical Cure after Primary and Reoperative Surgery for Sporadic Medullary Thyroid Carcinoma , 1998, World Journal of Surgery.